Debra (Debbie) Wilmington, Ph.D.

E-Mail:  debra.wilmington@va.gov
Telephone:  503-220-8262, ext. 52727
Fax:  503-721-1402

Current Appointments

Staff Investigator
Assistant Professor, Dept. Otolaryngology, Oregon Health and Science University

Research Interests
Ototoxicity and noise-induced hearing loss, plasticity of the central auditory system, binaural hearing.

Research Projects

A Portable Audiometric Monitoring Device (the OtoID), Debra Wilmington, Ph.D.
VA Rehabilitation Research & Development Service, 7/1/08 - 6/30/12.

Prevention of Cisplatin Ototoxicity with the Antioxidant α-Lipoic Acid, Debra Wilmington, Ph.D.
VA Rehabilitation Research & Development Service, 1/1/07-6/30/11.

Effect of Training on Central Auditory Function in Multiple Sclerosis, Dennis Bourdette, M.D.
VA Rehabilitation Research & Development Service, 1/1/07-6/30/11.

Selected Recent Publications
Hutter MM, Folmer RL, Shannon JM, Lewis MS, Wilmington DJ, Lilly DJ, Casiana L, Billings CJ, Fitzpatrick MA, Bourdette DN, Fausti SA. Central auditory processing deficits in multiple sclerosis patients. Intl J of MS Care, 2010; 12 (Supplement 1): 38.

Wilmington, D., Lewis, M.S., Myers, P., Gallun, E., & Fausti, S. (2010). Hearing Impairment Among Soldiers: Special Consideration for Amputees. In P. Pasquina (ed.) Care of the Combat Amputee. Bethesda: Borden Institute, Chapter 14:381-397.

Fausti SA, Wilmington DJ, Gallun FJ, Myers PJ, Henry JA. (2009). Auditory and Vestibular Dysfunction Associated with Traumatic Brain Injury. J Rehab Res Dev. 46(6):797–810.

Myers PJ, Wilmington DJ, Gallun FJ, Henry JA, Fausti SA. (2009). Hearing Impairment and Traumatic Brain Injury Among Soldiers: Special Considerations for the Audiologist. Seminars in Hearing Journal, 30(1):5-27, 2009.

Lewis MS, Wilmington DJ, Hutter MM, Lily DJ, Bourdette DN, Fausti SA. (2008). Auditory function in individuals with multiple sclerosis. MS Focus, 10(1), 12-15.

Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington DJ, Bratt GW, Konrad-Martin D. (2008). Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss. Ear and Hear. 29(6):875-93.

Konrad-Martin, D., Wilmington, D.J., Gordon, J.S., Reavis, K.M. & Fausti, S.A. (2005). Audiological Management of Patients Receiving Aminoglycoside Antibiotics. Volta Review.105(3):229-250.

Fausti, S.A., Wilmington, D.J., Helt, P.V., & Helt, W.J. (2005). Hearing Health and Care - The Need for Improved Hearing Loss Prevention and Hearing Conservation Practices. J Rehab Res Dev, 42(4).

Konrad-Martin, D., Gordon, J.S., Reavis, K.M., Wilmington, D.J., & Helt, W.J. (2005). Audiological Monitoring of Patients Receiving Ototoxic Drugs. ASHA Perspec, 9(1), 17-22.

For additional information on research, presentations and publications see : complete CV.